期刊文献+

氟康唑片在中国汉族和回族健康志愿者体内的药动学研究

Study of pharmacokinetics of fluconazole tablets in Chinese healthy ethnic Han and Hui volunteers
下载PDF
导出
摘要 目的:研究汉族和回族健康志愿者单剂量口服氟康唑片的药动学。方法:健康汉族和回族受试者各10名,男女各半,口服氟康唑片200mg,定时采血,用RP-HPLC法测定血药浓度,以DAS软件程序计算药动学参数。结果:汉族和回族受试者的主要药动学参数分别为Cmax(4.91±0.67)和(5.22±1.04)mg/L;tmax(1.90±0.90)和(2.20±1.30)h;t1/2(33.07±5.90)和(34.08±7.01)h;AUC0~96(189.61±32.91)和(197.21±49.35)mg·h·L^-1,AUC0-∞,(219.21±40.46)和(231.97±70.11)mg·h·L^-1。统计结果显示两民族受试者主要药动学参数无显著性差异。结论:汉族和回族受试者的氟康唑药动学无显著性差异。 Objective:To investigate the pharmacokinetics of fluconazole tablets after oral administration in Chinese healthy ethnic Han and Hui volunteers. Methods:Ten healthy volunteers each of Chinese ethnic Han and Hui (5 males and 5 females in each group) were orally given 200 mg fluconazole tablets. Blood samples were taken at predetermined time. The concentrations of fluconazole in plasma were determined by RP-HPLC method and pharmacokinetic parameters were calculated by DAS software. Results:The pharmacokinetic parameters of Han and H ui volunteers were as follows:Cmax (4. 91 ±0. 67) and (5. 22 ± 1.04) mg/L,tmax(1.90±0.90) and (2. 20±1.30) h,t1/2(33.07±5.90) and (34.08±7.01) h, AUC0-96 (189.61±32.91) and (197.21±49.35) mg·h·L^-1, AUC0-∞(219.21±40.46) and (231. 97±70.11) mg·h·L^-1,respectively.Statisticalanalysis showed no significant difference in main pharmacokinetic parameters of fluconazole between two ethnics. Conclusion:There is no significant difference in pharmacokinetics of fluconazole tablets between Chinese Han and Hui volunteers.
出处 《药学服务与研究》 CAS CSCD 2008年第3期216-219,共4页 Pharmaceutical Care and Research
基金 全军医学科学技术研究"十一五"计划科技攻关课题基金资助项目(No.06G023)
关键词 氟康唑 药代动力学 色谱法 高压液相 汉族 回族 fluconazole pharmacokinetics chromatography,high pressure liquid Han nationality Hui nationality
  • 相关文献

参考文献6

二级参考文献29

  • 1白林,张志萍,陈秀兰,徐向阳.高效液相色谱法测定氟康唑血药浓度[J].药物分析杂志,1994,14(2):22-23. 被引量:12
  • 2付桂英,郭晓华,赵颖,杨珺,吴坤.注射用氟康唑的制备工艺及稳定性研究[J].中国药房,2005,16(11):832-834. 被引量:1
  • 3杜智敏,孙考祥,张波.氟康唑胶囊人体生物利用度及药动学研究[J].中国药学杂志,2006,41(6):451-453. 被引量:12
  • 4[1]Aarons L, Hopkins K, Rowland M, et al. Route of administration and sex differences in the pharmacokinetics of asprin, administered as its lysine salt[J]. Pharm Res, 1989;6:660-666.
  • 5[2]Ho PC, Triggs EJ, Bourn DWA, et al. The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites[J]. Br J Clin Pharmacol, 1985;19:675-684.
  • 6[3]Schuetz EG, Furuya KN, Schuetz JD. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms[J]. J Pharmacol Exp Ther, 1995;275:1011-1018.
  • 7[4]Meibohm B, Beierle I, Derendorf H. How important are gender differences in pharmacokinetics[J]. Clin Pharmacokinet, 2002;41:329-342.
  • 8[5]Watkins PB, Turgeon DK, Saenger P, et al. Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450 Ⅲ A(CYP3A) activity[J]. Clin Pharmacol Ther,1992; 52:265-273.
  • 9[6]Rugstad HE, Hundal O, Holme I, et al. Piroxicam and naproxen plasma concentrations in patients with osteoarthritis: relation to age, sex, efficacy and adverse events[J]. Clin Rheumatol, 1986;5:389-398.
  • 10[7]Hagg S, Spigset O, Dahlqvist R. Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers[J]. Br J Clin Pharmacol, 2001 ;51:169-173.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部